
Genotropin’s Impact on Prader-Willi Syndrome in American Males: A Decade-Long Study
Reading Time: 3 minutes Introduction Prader-Willi Syndrome (PWS) is a complex genetic disorder that presents significant challenges to affected individuals and their families. Characterized by hypotonia, feeding difficulties in infancy, and later by hyperphagia leading to obesity, PWS also includes developmental delays and cognitive impairments. Among various therapeutic approaches, Genotropin, a recombinant human growth hormone, has been utilized to address some of the growth and metabolic issues associated with PWS. This article explores the role of Genotropin in managing PWS in American males over a decade, offering a comparative analysis of its efficacy and impact. Overview of Prader-Willi Syndrome Prader-Willi Syndrome is caused by...